Antithymocyte Globulin: Indiscriminate Use and Complications

The safety profile of rATG is impressive, with its use in 40% of inductions in living donor transplants in the US, with a reduced incidence of acute rejection, a low incidence of CMV infections with universal prophylaxis and enabling steroid sparing regimes.

Detalles Bibliográficos
Autores principales: Khan, Taqi, Mirza, Irfan, Anwar, Nisar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Letter To Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886324/
https://www.ncbi.nlm.nih.gov/pubmed/31754089
http://dx.doi.org/10.12659/AOT.919655
_version_ 1783474858181525504
author Khan, Taqi
Mirza, Irfan
Anwar, Nisar
author_facet Khan, Taqi
Mirza, Irfan
Anwar, Nisar
author_sort Khan, Taqi
collection PubMed
description The safety profile of rATG is impressive, with its use in 40% of inductions in living donor transplants in the US, with a reduced incidence of acute rejection, a low incidence of CMV infections with universal prophylaxis and enabling steroid sparing regimes.
format Online
Article
Text
id pubmed-6886324
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-68863242019-12-09 Antithymocyte Globulin: Indiscriminate Use and Complications Khan, Taqi Mirza, Irfan Anwar, Nisar Ann Transplant Letter To Editor The safety profile of rATG is impressive, with its use in 40% of inductions in living donor transplants in the US, with a reduced incidence of acute rejection, a low incidence of CMV infections with universal prophylaxis and enabling steroid sparing regimes. International Scientific Literature, Inc. 2019-11-22 /pmc/articles/PMC6886324/ /pubmed/31754089 http://dx.doi.org/10.12659/AOT.919655 Text en © Ann Transplant, 2019 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Letter To Editor
Khan, Taqi
Mirza, Irfan
Anwar, Nisar
Antithymocyte Globulin: Indiscriminate Use and Complications
title Antithymocyte Globulin: Indiscriminate Use and Complications
title_full Antithymocyte Globulin: Indiscriminate Use and Complications
title_fullStr Antithymocyte Globulin: Indiscriminate Use and Complications
title_full_unstemmed Antithymocyte Globulin: Indiscriminate Use and Complications
title_short Antithymocyte Globulin: Indiscriminate Use and Complications
title_sort antithymocyte globulin: indiscriminate use and complications
topic Letter To Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886324/
https://www.ncbi.nlm.nih.gov/pubmed/31754089
http://dx.doi.org/10.12659/AOT.919655
work_keys_str_mv AT khantaqi antithymocyteglobulinindiscriminateuseandcomplications
AT mirzairfan antithymocyteglobulinindiscriminateuseandcomplications
AT anwarnisar antithymocyteglobulinindiscriminateuseandcomplications

Ejemplares similares